This course has concluded on May 29, 2022

CE InformationCourse Outline

    Managing Dialysis Access in the COVID-19 Environment

    FACULTY

    John Ross, MD - Moderator 
    Lead Surgeon/Medical Director
    Dialysis Access Institute
    Regional Medical Center
    Orangeburg, South Carolina

    Ari D. Kramer, MD
    Assistant Professor of Surgery
    Director, Vascular Access Surgery and Intervention
    Former Chairman of Surgery
    Spartanburg Hospital System
    Spartanburg, South Carolina

    Terry F. Litchfield, MPA, CPC
    Patient Advocate
    President, Access Solutions
    Blanchardville, Wisconsin

    Charmaine E. Lok, MD, MSc, FRCP(C)
    Professor of Medicine
    University of Toronto
    Senior Scientist
    Toronto General Research Institute
    Toronto, ON, Canada

    Monnie Wasse, MD, MPH, FASN, FASDIN
    Professor of Medicine
    Vice Chair Operations, Dept of Medicine
    Director, Interventional Nephrology
    Rush University Medical Center
    Past-President, American Society of Diagnostic & Interventional Nephrology
    Chicago, Illinois

     

    PROVIDER STATEMENT

    Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

     For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

    INTENDED LEARNERS

    This activity is designed for nephrologists, vascular surgeons, interventional radiologists, nurses, PAs, vascular and interventional techs. 

    LEARNING OBJECTIVES

    After participating in this activity, participants should be better able to:

    • Understand the recently published guidelines for managing failed access, and how to interpret in this current environment
    • Identify technologies available to prevent high-risk patients from having to go into the hospital and demonstrate an ability to utilize
    • Identify an appropriate treatment algorithm for end-stage kidney disease patients during this pandemic, as well as beyond
     

    CLAIMING CREDIT

    To be eligible for credit, participants must watch the webcast, complete the post-test with a score of 70% or better, and complete the evaluation. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

    Release date: May 29, 2020
    Expiration date: May 29, 2022
    Time to complete: 1 hour

    There is no fee associated with this activity.

     

    COMMERCIAL SUPPORT

    NACCME would like to thank the following company/companies who has/have supported the "Managing your AV Patients in the COVID-19 Environment" through educational grants and/or in-kind support: Medtronic

    CONTINUING EDUCATION

     In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    PHYSICIANS

    NACCME designates this internet live/enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NURSING

    This continuing nursing education activity awards 1.0 contact hour.

    Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

     

    PHYSICIAN ASSISTANTS

    NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.

    VASCULAR & INTERVENTIONAL RADIOGRAPHERS

    Managing Dialysis Access in the COVID-19 Environment taking place from May 29, 2020 to May 29, 2022 has been approved for 1.0 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

    USE OF PROPRIETARY NAMES

    This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

    UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

    This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

    DISCLAIMERS

    The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

    Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

    The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

     

    DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

    NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

    NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

    According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

    Clinical Reviewers

    Peter Oettgen, MD
    Preventive Cardiology
    Beth Israel Deaconess Medical Center
    Boston, MA

    Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA

    Planning Committee

    In addition to the faculty listed below, NACCME planners and staff include Chris Bolwell, Samantha Conforti, Randy Robbin, Margie Stefan, and Colleen Waters. 

    Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

    Faculty
    The faculty has reported the following:

    Dr. Kramer: Consultant—Medtronic

    Dr. Lok: Consultant—BD, Medtronic

    Ms. Seaman: Speakers' Bureau—Next Science

    Dr. Wasse: Consultant—Avenu Medical, Diaxamed; Speakers' Bureau—Bard Peripheral, WL Gore

    Ms. Litchfield, Dr. Oettgen, and Dr. Ross have disclosed no relevant financial relationships with any commercial interests.

     

    ADA STATEMENT

    North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

    PRIVACY POLICY

    NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

    Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.